GlaxoSmithKline Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | NSE: GLAXO | BSE: 500660
₹2,508.80 -60.65 (-2.36 %)
Last Updated: 21 Feb 2025 04:01 PM
Overview
Open (₹) 2,583.15
High (₹) 2,586.00
Low (₹) 2,487.55
Prev. Close (₹) 2,569.45
Volume 10,554
VWAP (₹) 2,543.15
ROCE (%) 47.33
Industry P/E 43.99
TTM P/E 49.46
P/B Ratio 23.91
Market Cap (₹) Cr.42,498.89
Dividend Yield (%)1.28
EPS (₹) 34.83
ROE33.19%
Sales Growth (%) 6.21
Profit Growth (%)-3.39
Day Range
2,586.002,586.00
52 Week Range
1,825.053,087.95
Historical Returns
Returns (6M)
-13.65 %
Returns (1Y)
15.67 %
Returns (3Y)
60.41 %
Returns (5Y)
87.42 %
Returns (6M)
-13.65 %
Returns (1Y)
15.67 %
Returns (3Y)
60.41 %
Returns (5Y)
87.42 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with no debt
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- High CCI indicates strong upward momentum.
- Positive ROC (9) indicates upward momentum.
- Strong trend indicated by ADX above 25.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
RSI 76.24
MFI 84.15
ATR 155.16
Commodity Channel Index 143.19
ROC125 -14.79
ROC21 19.83
Williams %R -29.70
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 2,567.35 | 2,625.90 | 2,665.80 | 2,527.45 | 2,468.90 | 2,429.00 | 2,370.45 |
Week Ago | 2,049.16 | 2,080.58 | 2,121.16 | 2,008.58 | 1,977.16 | 1,936.58 | 1,905.16 |
Month Ago | 2,188.80 | 2,235.50 | 2,270.50 | 2,153.80 | 2,107.10 | 2,072.10 | 2,025.40 |
EMA & SMA
2508.80
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 2437.47
9 Day 2238.06
10 Day 2246.08
12 Day 2206.88
14 Day 2187.69
20 Day 2139.44
26 Day 2140.73
50 Day 2182.71
100 Day 2377.66
200 Day 2496.27
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 17 Oct, 2022 | ₹1,378.65 | 11,841 | BSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 17 Oct, 2022 | ₹1,378.65 | 80,615 | BSE |
ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 17 Oct, 2022 | ₹1,378.65 | 11,841 | BSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 17 Oct, 2022 | ₹1,378.65 | 80,615 | BSE |
ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 11 Oct, 2022 | ₹1,393.45 | 11,417 | BSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 11 Oct, 2022 | ₹1,393.45 | 77,734 | BSE |
ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 11 Oct, 2022 | ₹1,393.45 | 11,417 | BSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 11 Oct, 2022 | ₹1,393.45 | 77,734 | BSE |
ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 19 Sept, 2022 | ₹1,431.75 | 10,499 | BSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 19 Sept, 2022 | ₹1,431.75 | 72,154 | BSE |
Insider Trading
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
24 Oct, 2024 | Rs.12.0000 per share(120%)Interim Dividend | 07 Nov, 2024 | 07 Nov, 2024 |
17 May, 2024 | Rs.32.0000 per share(320%)Final Dividend | 31 May, 2024 | 31 May, 2024 |
17 May, 2023 | Rs.32.0000 per share(320%)Final Dividend | 30 Jun, 2023 | 30 Jun, 2023 |
Announcements
Date | Source | Detail |
---|---|---|
18 Feb, 2025 | NSE India | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Rumour Verification - Regulation 30(11) |
18 Feb, 2025 | BSE India | As per attachment |
17 Feb, 2025 | NSE India | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication |
17 Feb, 2025 | NSE India | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript |
17 Feb, 2025 | BSE India | Transcript of Analyst Meet |
15 Feb, 2025 | BSE India | as per attachment |
15 Feb, 2025 | NSE India | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Link of Recording |
14 Feb, 2025 | NSE India | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
14 Feb, 2025 | BSE India | Revsied outcome of meeting |
14 Feb, 2025 | NSE India | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on February 14, 2025. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | (Revised) | 21 Jan, 2025 | 14 Feb, 2025 |
Quarterly Results | (Cancelled) | 21 Jan, 2025 | 10 Feb, 2025 |
Quarterly Results & Interim Dividend | -- | 25 Oct, 2024 | 29 Oct, 2024 |
Quarterly Results | -- | 19 Jul, 2024 | 02 Aug, 2024 |
Audited Results & Final Dividend | -- | 22 Apr, 2024 | 17 May, 2024 |
Quarterly Results | -- | 05 Jan, 2024 | 12 Feb, 2024 |
Quarterly Results | -- | 05 Oct, 2023 | 09 Nov, 2023 |
Quarterly Results | -- | 03 Jul, 2023 | 26 Jul, 2023 |
Audited Results & Final Dividend | -- | 04 May, 2023 | 17 May, 2023 |
Quarterly Results | -- | 12 Jan, 2023 | 07 Feb, 2023 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
---|
About GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals is a Public Limited Listed company incorporated on 13/11/1924 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1924PLC001151 and registration number is 001151. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 3407.25 Cr. and Equity Capital is Rs. 169.41 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
MNC Associate
Founded
1924
Managing Director
Mr. B Akshikar
NSE Symbol
GLAXO
GlaxoSmithKline Pharmaceuticals Management
Name | Designation |
---|---|
Ms. R S Karnad | Chairperson |
Mr. B Akshikar | Managing Director |
Mr. J Chandy | WholeTime Director & CFO |
Mr. S Williams | Non Executive Director |
Mr. M Anand | Independent Director |
Dr.(Ms.) S Maheshwari | Independent Director |
Mr. A N Roy | Independent Director |
Mr. D Sundaram | Independent Director |
Mr. P V Bhide | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
SunPhrmInds | ₹4,46,576.22 | ₹1,643.75 ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on GlaxoSmithKline Pharmaceuticals
What is the share price of GlaxoSmithKline Pharmaceuticals?
The share price of GlaxoSmithKline Pharmaceuticals on 21 Feb, 2025 is ₹ 2,508.80.
What is 52W high and 52W low share price of GlaxoSmithKline Pharmaceuticals?
The highest and lowest 52W share prices of GlaxoSmithKline Pharmaceuticals are ₹ 3087.950 and ₹ 1799.050
What is the market cap of GlaxoSmithKline Pharmaceuticals?
The market capitalization of GlaxoSmithKline Pharmaceuticals as of 21 Feb, 2025 is ₹ 42,498.89 Crores
What is the P/E ratio of GlaxoSmithKline Pharmaceuticals?
The current P/E ratio of GlaxoSmithKline Pharmaceuticals as of 21 Feb, 2025 is 43.99
What is the PB ratio of GlaxoSmithKline Pharmaceuticals?
The PB ratio of GlaxoSmithKline Pharmaceuticals as of 21 Feb, 2025 is 23.91
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)